Patented IRPL® Technology Now Available in Canada

I-MED Pharma announces Health Canada approval for the E>Eye Laser, which is now available to Canadian eye care professionals  With...

Read More

Appeal Court Upholds I-MED Pharma’s Patent Win Against TearLab

The Canadian Federal Court of Appeal confirmed that TearLab’s efforts to keep the I-PEN® Osmolarity System, marketed by I-MED Pharma, off the...

Read More

I-MED Pharma partners with OCuSOFT to bring the I-PEN to USA

I-MED Pharma Inc, a Canadian company based in Montreal specializing in dry eye diagnosis and management, announced the signing of an exclusive...

Read More